Trial
NCT04698915
Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Galera Therapeutics, Inc.
Collaborators
—
Condition
SBRT
Intervention
Drug GC4711
Why stopped
Futility Analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-21